Investigating MTMR6: A Protein Involved in Many Cellular Processes

Target Name: MTMR6

NCBI ID: G9107

MTMR6

Investigating MTMR6: A Protein Involved in Many Cellular Processes

MTMR6 (MTMR6_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the superfamily of the leucine-rich repeat (LRR) domain containing proteins, which are characterized by the presence of a specific motif in their amino acid sequence.

MTMR6 is involved in many different cellular processes in the body, including cell signaling, DNA replication, and metabolism. It is a key regulator of the cell cycle, and is involved in the G1/S transition, G2/M transition, and G0/G1 transition. MTMR6 is also involved in the regulation of cell adhesion, and is thought to play a role in the development of cancer.

Due to its involvement in so many different cellular processes, MTMR6 has been identified as a potential drug target. Researchers are currently working to develop small molecules that can inhibit the activity of MTMR6, with the goal of using these drugs to treat a variety of diseases.

One of the challenges in studying MTMR6 is its complex structure. Because it is a protein that is expressed in many different tissues of the body, it is difficult to study its activity in a specific context. Researchers have used a variety of techniques to study the behavior of MTMR6, including cell-based assays, biochemical assays, and in vitro assays.

In addition to its involvement in the cell cycle, MTMR6 is also involved in the regulation of cell adhesion. This is important because MTMR6 is thought to play a role in the development of cancer, and because the regulation of cell adhesion is often disrupted in cancer cells. Researchers are currently working to understand the mechanisms by which MTMR6 regulates cell adhesion, and to identify potential drug targets that can inhibit its activity.

One potential approach to studying MTMR6 is to use small molecules that can inhibit its activity. Researchers have identified a number of small molecules that have been shown to inhibit the activity of MTMR6, and are currently working to test these molecules for their potential as drug treatments. These molecules can include inhibitors of the activity of MTMR6 itself, as well as compounds that bind toMTMR6 and prevent it from interacting with its downstream targets.

Another approach to studying MTMR6 is to use biochemical assays to study its behavior in the cell. For example, researchers have used assays such as immunofluorescence microscopy and biochemical assays to study the distribution and activity of MTMR6 in different tissues of the human body. These studies have provided valuable insights into the role of MTMR6 in cellular processes, and have identified potential drug targets that can be targeted by small molecules.

In conclusion, MTMR6 is a protein that is involved in many different cellular processes in the human body. It is a key regulator of the cell cycle, and is also involved in the regulation of cell adhesion. As a result, it has been identified as a potential drug target, and researchers are currently working to develop small molecules that can inhibit its activity. These small molecules can include inhibitors of the activity of MTMR6 itself, as well as compounds that bind toMTMR6 and prevent it from interacting with its downstream targets. Further studies are needed to fully understand the role of MTMR6 in cellular processes, and to identify potential drug targets that can be used to treat a variety of diseases.

Protein Name: Myotubularin Related Protein 6

Functions: Phosphatase that acts on lipids with a phosphoinositol headgroup (PubMed:19038970, PubMed:22647598). Dephosphorylates phosphatidylinositol 3-phosphate (PtdIns(3)P) and phosphatidylinositol 3,5-bisphosphate (PubMed:19038970, PubMed:22647598) (Probable). Binds with high affinity to phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) but also to phosphatidylinositol 3-phosphate (PtdIns(3)P), phosphatidylinositol 4-phosphate (PtdIns(4)P), and phosphatidylinositol 5-phosphate (PtdIns(5)P), phosphatidic acid and phosphatidylserine (PubMed:19038970). Negatively regulates ER-Golgi protein transport (By similarity). Probably in association with MTMR9, plays a role in the late stages of macropinocytosis by dephosphorylating phosphatidylinositol 3-phosphate in membrane ruffles (PubMed:24591580). Acts as a negative regulator of KCNN4/KCa3.1 channel activity in CD4(+) T-cells possibly by decreasing intracellular levels of phosphatidylinositol 3-phosphate (PubMed:15831468). Negatively regulates proliferation of reactivated CD4(+) T-cells (PubMed:16847315). In complex with MTMR9, negatively regulates DNA damage-induced apoptosis (PubMed:19038970, PubMed:22647598). The formation of the MTMR6-MTMR9 complex stabilizes both MTMR6 and MTMR9 protein levels (PubMed:19038970)

The "MTMR6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTMR6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets